{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:10:14Z","timestamp":1791382214955,"version":"4.3.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R21DC019450"],"award-info":[{"award-number":["R21DC019450"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DC017264"],"award-info":[{"award-number":["R01DC017264"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DC005575"],"award-info":[{"award-number":["R01DC005575"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DC012115"],"award-info":[{"award-number":["R01DC012115"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R25 DC020726"],"award-info":[{"award-number":["R25 DC020726"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["K08DC017508"],"award-info":[{"award-number":["K08DC017508"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04281-x","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:46:17Z","timestamp":1743849977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated human Schwann cell proliferation"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0093-030X","authenticated-orcid":false,"given":"Pei-Ciao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyoung","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson B.","family":"Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena R.","family":"Bracho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Del","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine T.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Dykxhoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"9","key":"4281_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrn1746","volume":"6","author":"KRMR Jessen","year":"2005","unstructured":"Jessen KRMR. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci. 2005;6(9):671\u201382.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"4281_CR2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/lary.25697","volume":"126","author":"WP Kennedy","year":"2016","unstructured":"Kennedy WP, Brody RM, LiVolsi VA, Wang AR, Mirza NA. Trauma-induced Schwannoma of the recurrent laryngeal nerve after thyroidectomy. Laryngoscope. 2016;126(6):1408\u201310.","journal-title":"Laryngoscope"},{"issue":"10","key":"4281_CR3","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/ajmg.a.63346","volume":"191","author":"A Goetsch Weisman","year":"2023","unstructured":"Goetsch Weisman A, Weiss McQuaid S, Radtke HB, Stoll J, Brown B, Gomes A. Neurofibromatosis- and schwannomatosis-associated tumors: approaches to genetic testing and counseling considerations. Am J Med Genet Part A. 2023;191(10):2467\u201381.","journal-title":"Am J Med Genet Part A"},{"issue":"13","key":"4281_CR4","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/hmg\/7.13.2051","volume":"7","author":"L Kluwe","year":"1998","unstructured":"Kluwe L, Mautner V-F. Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet. 1998;7(13):2051\u20135.","journal-title":"Hum Mol Genet"},{"key":"4281_CR5","unstructured":"DG. E. NF2-Related Schwannomatosis.: Seattle (WA): University of Washington, Seattle. 1998 [updated 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1201\/"},{"issue":"5","key":"4281_CR6","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1097\/MAO.0000000000002613","volume":"41","author":"CT Dinh","year":"2020","unstructured":"Dinh CT, Nisenbaum E, Chyou D, Misztal C, Yan D, Mittal R, et al. Genomics, epigenetics, and hearing loss in neurofibromatosis type 2. Otol Neurotol. 2020;41(5):e529\u201337.","journal-title":"Otol Neurotol"},{"issue":"9","key":"4281_CR7","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med. 2022;24(9):1967\u201377.","journal-title":"Genet Med"},{"issue":"1","key":"4281_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12964-020-00544-7","volume":"18","author":"M Mota","year":"2020","unstructured":"Mota M, Shevde LA. Merlin regulates signaling events at the nexus of development and cancer. Cell Commun Signal. 2020;18(1):63.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"4281_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.otc.2023.02.004","volume":"56","author":"A Nourbakhsh","year":"2023","unstructured":"Nourbakhsh A, Dinh CT. Updates on tumor biology in vestibular Schwannoma. Otolaryngol Clin North Am. 2023;56(3):421\u201334.","journal-title":"Otolaryngol Clin North Am"},{"issue":"3","key":"4281_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jb\/mvad105","volume":"175","author":"I Yamaguchi","year":"2024","unstructured":"Yamaguchi I, Katoh H. Merlin\/NF2 regulates SLC7A11\/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells. J Biochem. 2024;175(3):313\u201322.","journal-title":"J Biochem"},{"issue":"3","key":"4281_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2741\/4817","volume":"25","author":"X Wu","year":"2020","unstructured":"Wu X, Mao F, Li N, Li W, Luo Y, Shi W, et al. NF2\/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells. Front Biosci (Landmark Ed). 2020;25(3):513\u201325.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"8","key":"4281_CR12","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/glia.24570","volume":"72","author":"L Baudouin","year":"2024","unstructured":"Baudouin L, Ad\u00e8s N, Kant\u00e9 K, Bachelin C, Hmidan H, Deboux C, et al. Antagonistic actions of PAK1 and NF2\/Merlin drive Myelin membrane expansion in oligodendrocytes. Glia. 2024;72(8):1518\u201340.","journal-title":"Glia"},{"issue":"17\u201318","key":"4281_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1101\/gad.317354.118","volume":"32","author":"C Chiasson-MacKenzie","year":"2018","unstructured":"Chiasson-MacKenzie C, Morris ZS, Liu CH, Bradford WB, Koorman T, McClatchey AI. Merlin\/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface. Genes Dev. 2018;32(17\u201318):1201\u201314.","journal-title":"Genes Dev"},{"issue":"2","key":"4281_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.bjc.6604002","volume":"98","author":"M Curto","year":"2008","unstructured":"Curto M, McClatchey A. Nf2\/Merlin: a coordinator of receptor signalling and intercellular contact. Br J Cancer. 2008;98(2):256\u201362.","journal-title":"Br J Cancer"},{"issue":"10","key":"4281_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.11.10.1253","volume":"11","author":"AISI McClatchey","year":"1997","unstructured":"McClatchey AISI, Ramesh V, Gusella JF, Jacks T. The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev. 1997;11(10):1253\u201365.","journal-title":"Genes Dev"},{"issue":"3","key":"4281_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/life14030417","volume":"14","author":"MHM Chalak","year":"2024","unstructured":"Chalak MHM, Mirbahari SN, Yeganeh M, Abdi S, Rajabi S, Hemmatzadeh F. Cell immortality: in vitro effective techniques to achieve and investigate its applications and challenges. Life. 2024;14(3):417.","journal-title":"Life"},{"issue":"6","key":"4281_CR17","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.stemcr.2017.04.011","volume":"8","author":"HSLJ Kim","year":"2017","unstructured":"Kim HSLJ, Lee DY, Kim YD, Kim JY, Lim HJ, Lim S, Cho YS. Schwann cell precursors from human pluripotent stem cells as a potential therapeutic target for Myelin repair. Stem Cell Rep. 2017;8(6):1714\u201326.","journal-title":"Stem Cell Rep"},{"key":"4281_CR18","doi-asserted-by":"crossref","unstructured":"Majd HAS, Ghazizadeh Z, Cesiulis A, Arroyo E, Lankford K, Majd A, Farahvashi S, Chemel AK, Okoye M, Scantlen MD, Tchieu J, Calder EL, Le Rouzic V, Shibata B, Arab A, Goodarzi H, Pasternak G, Kocsis JD, Chen S, Studer L, Fattahi F. Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy. Cell Stem Cell. 2023;30:632\u2013\u200947.e10.","DOI":"10.1016\/j.stem.2023.04.006"},{"issue":"3","key":"4281_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","volume":"7","author":"DHGR Gutmann","year":"1998","unstructured":"Gutmann DHGR, Xu Hm, Kim JS, Saporito-Irwin S. Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum Mol Genet. 1998;7(3):335\u201345.","journal-title":"Hum Mol Genet"},{"key":"4281_CR20","doi-asserted-by":"publisher","first-page":"102474","DOI":"10.1016\/j.scr.2021.102474","volume":"55","author":"A Nourbakhsh","year":"2021","unstructured":"Nourbakhsh A, Gosstola NC, Fernandez-Valle C, Dykxhoorn DM, Liu XZ. Characterization of UMi031-A-2 inducible pluripotent stem cell line with a neurofibromatosis type 2-associated mutation. Stem Cell Res. 2021;55:102474.","journal-title":"Stem Cell Res"},{"issue":"2","key":"4281_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/hmg\/8.2.267","volume":"8","author":"DH Gutmann","year":"1999","unstructured":"Gutmann DH, Sherman L, Seftor L, Haipek C, Hoang Lu K, Hendrix M. Increased expression of the NF2 tumor suppressor gene product, Merlin, impairs cell motility, adhesion and spreading. Hum Mol Genet. 1999;8(2):267\u201375.","journal-title":"Hum Mol Genet"},{"issue":"14","key":"4281_CR22","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/hmg\/10.14.1519","volume":"10","author":"DHHA Gutmann","year":"2001","unstructured":"Gutmann DHHA, Haipek CA. Functional analysis of neurofibromatosis 2 (NF2) missense mutations. Hum Mol Genet. 2001;10(14):1519\u201329.","journal-title":"Hum Mol Genet"},{"issue":"17","key":"4281_CR23","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1128\/MCB.00664-07","volume":"27","author":"L Levy","year":"2007","unstructured":"Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS. Arkadia activates Smad3\/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol. 2007;27(17):6068\u201383.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"4281_CR24","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1158\/0008-5472.CAN-12-1916","volume":"73","author":"MA Briones-Orta","year":"2013","unstructured":"Briones-Orta MA, Levy L, Madsen CD, Das D, Erker Y, Sahai E, et al. Arkadia regulates tumor metastasis by modulation of the TGF-\u03b2 pathway. Cancer Res. 2013;73(6):1800\u201310.","journal-title":"Cancer Res"},{"issue":"1","key":"4281_CR25","first-page":"603","volume":"84","author":"D EVANS","year":"1992","unstructured":"EVANS D, HUSON S, DONNAI D, NEARY W. A clinical study of type 2 neurofibromatosis. QJM: Int J Med. 1992;84(1):603\u201318.","journal-title":"QJM: Int J Med"},{"issue":"52","key":"4281_CR26","doi-asserted-by":"publisher","first-page":"18200","DOI":"10.1073\/pnas.0405971102","volume":"101","author":"R Rong","year":"2004","unstructured":"Rong R, Tang X, Gutmann DH, Ye K. Neurofibromatosis 2 (NF2) tumor suppressor Merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Proc Natl Acad Sci U S A. 2004;101(52):18200\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4281_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","volume":"1","author":"RJ Shaw","year":"2001","unstructured":"Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, et al. The Nf2 tumor suppressor, Merlin, functions in Rac-dependent signaling. Dev Cell. 2001;1(1):63\u201372.","journal-title":"Dev Cell"},{"issue":"5","key":"4281_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI. Contact-dependent Inhibition of EGFR signaling by Nf2\/Merlin. J Cell Biol. 2007;177(5):893\u2013903.","journal-title":"J Cell Biol"},{"issue":"2","key":"4281_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1083\/jcb.201503081","volume":"211","author":"C Chiasson-MacKenzie","year":"2015","unstructured":"Chiasson-MacKenzie C, Morris ZS, Baca Q, Morris B, Coker JK, Mirchev R, et al. NF2\/Merlin mediates contact-dependent Inhibition of EGFR mobility and internalization via cortical actomyosin. J Cell Biol. 2015;211(2):391\u2013405.","journal-title":"J Cell Biol"},{"issue":"15","key":"4281_CR30","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/MCB.01581-08","volume":"29","author":"MF James","year":"2009","unstructured":"James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, et al. NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and Schwannoma growth. Mol Cell Biol. 2009;29(15):4250\u201361.","journal-title":"Mol Cell Biol"},{"issue":"15","key":"4281_CR31","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1128\/MCB.01578-08","volume":"29","author":"MA L\u00f3pez-Lago","year":"2009","unstructured":"L\u00f3pez-Lago MA, Okada T, Murillo MM, Socci N, Giancotti FG. Loss of the tumor suppressor gene NF2, encoding Merlin, constitutively activates integrin-dependent mTORC1 signaling. Mol Cell Biol. 2009;29(15):4235\u201349.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4281_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ncb1339","volume":"8","author":"F Hamaratoglu","year":"2006","unstructured":"Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C, et al. The tumour-suppressor genes NF2\/Merlin and expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol. 2006;8(1):27\u201336.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"4281_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ng930","volume":"31","author":"CTY Fernandez-Valle","year":"2002","unstructured":"Fernandez-Valle CTY, Ricard J, Rodenas-Ruano A, Taylor A, Hackler E, Biggerstaff J, Iacovelli J. Paxillin binds Schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet. 2002;31(4):354\u201362.","journal-title":"Nat Genet"},{"key":"4281_CR34","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1242\/jcs.113.23.4139","volume":"113","author":"CE Turner","year":"2000","unstructured":"Turner CE. Paxillin interactions. J Cell Sci. 2000;113:4139\u201340.","journal-title":"J Cell Sci"},{"issue":"44","key":"4281_CR35","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1038\/sj.onc.1204786","volume":"20","author":"MD Schaller","year":"2001","unstructured":"Schaller MD. Paxillin: a focal adhesion-associated adaptor protein. Oncogene. 2001;20(44):6459\u201372.","journal-title":"Oncogene"},{"issue":"3","key":"4281_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7","volume":"51","author":"HMGD Xu","year":"1998","unstructured":"Xu HMGD. Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res. 1998;51(3):403\u201315.","journal-title":"J Neurosci Res"},{"key":"4281_CR37","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1242\/jcs.114.10.1901","volume":"114","author":"EGA Brault","year":"2001","unstructured":"Brault EGA, Lamarine M, Callebaut I, Thomas G, Goutebroze L. Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain. J Cell Sci. 2001;114:1901\u201312.","journal-title":"J Cell Sci"},{"key":"4281_CR38","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.mbplus.2021.100074","volume":"12","author":"MC Primi","year":"2021","unstructured":"Primi MC, Rangarajan ES, Patil DN, Izard T. Conformational flexibility determines the Nf2\/merlin tumor suppressor functions. Matrix Biology Plus. 2021;12:100074.","journal-title":"Matrix Biology Plus"},{"issue":"3","key":"4281_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1086\/302812","volume":"66","author":"RP Stokowski","year":"2000","unstructured":"Stokowski RP, Cox DR. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Am J Hum Genet. 2000;66(3):873\u201391.","journal-title":"Am J Hum Genet"},{"issue":"20","key":"4281_CR40","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1016\/j.molcel.2021.07.040","volume":"81","author":"F Meng","year":"2021","unstructured":"Meng F, Yu Z, Zhang D, Chen S, Guan H, Zhou R, et al. Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity. Mol Cell. 2021;81(20):4147\u2013e647.","journal-title":"Mol Cell"},{"issue":"8","key":"4281_CR41","doi-asserted-by":"publisher","first-page":"e202302043","DOI":"10.26508\/lsa.202302043","volume":"6","author":"CS Moesslacher","year":"2023","unstructured":"Moesslacher CS, Auernig E, Woodsmith J, Feichtner A, Jany-Luig E, Jehle S, et al. Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function. Life Sci Alliance. 2023;6(8):e202302043.","journal-title":"Life Sci Alliance"},{"issue":"12","key":"4281_CR42","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.109.208785","volume":"105","author":"W Zhu","year":"2009","unstructured":"Zhu W, Trivedi CM, Zhou D, Yuan L, Lu MM, Epstein JA. Inpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness. Circ Res. 2009;105(12):1240\u20137.","journal-title":"Circ Res"},{"issue":"9","key":"4281_CR43","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1158\/0008-5472.CAN-08-3931","volume":"69","author":"M Okada","year":"2009","unstructured":"Okada M, Wang Y, Jang SW, Tang X, Neri LM, Ye K. Akt phosphorylation of Merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of Merlin. Cancer Res. 2009;69(9):4043\u201351.","journal-title":"Cancer Res"},{"issue":"4","key":"4281_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","volume":"140","author":"W Li","year":"2010","unstructured":"Li W, You L, Cooper J, Schiavon G, Pepe-Caprio A, Zhou L, et al. Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell. 2010;140(4):477\u201390.","journal-title":"Cell"},{"key":"4281_CR45","doi-asserted-by":"crossref","unstructured":"Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, et al. Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-\u03b2 Signaling*. Journal of Biological Chemistry. 2007;282(28):20492-501.","DOI":"10.1074\/jbc.M701294200"},{"issue":"20","key":"4281_CR46","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1158\/0008-5472.CAN-11-1645","volume":"71","author":"V Sharma","year":"2011","unstructured":"Sharma V, Antonacopoulou AG, Tanaka S, Panoutsopoulos AA, Bravou V, Kalofonos HP, et al. Enhancement of TGF-\u03b2 signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer. Cancer Res. 2011;71(20):6438\u201349.","journal-title":"Cancer Res"},{"key":"4281_CR47","doi-asserted-by":"crossref","unstructured":"Laigle V, Dingli F, Amhaz S, Perron T, Chouch\u00e8ne M, Colasse S, et al. Quantitative Ubiquitylome Analysis Reveals the Specificity of RNF111\/Arkadia E3 Ubiquitin Ligase for its Degradative Substrates SKI and SKIL\/SnoN in TGF-\u03b2 Signaling Pathway.Molecular & Cellular Proteomics. 2021;20.","DOI":"10.1016\/j.mcpro.2021.100173"},{"key":"4281_CR48","doi-asserted-by":"crossref","unstructured":"Xu H, Wu L, Nguyen HH, Mesa KR, Raghavan V, Episkopou V et al. Arkadia-SKI\/SnoN signaling differentially regulates TGF-\u03b2\u2013induced iTreg and Th17 cell differentiation. J Exp Med. 2021;218(11).","DOI":"10.1084\/jem.20210777"},{"issue":"4","key":"4281_CR49","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/MCB.01139-07","volume":"28","author":"BK Cole","year":"2008","unstructured":"Cole BK, Curto M, Chan AW, McClatchey AI. Localization to the cortical cytoskeleton is necessary for Nf2\/merlin-dependent epidermal growth factor receptor Silencing. Mol Cell Biol. 2008;28(4):1274\u201384.","journal-title":"Mol Cell Biol"},{"issue":"Pt 22","key":"4281_CR50","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1242\/jcs.045914","volume":"122","author":"D Lallemand","year":"2009","unstructured":"Lallemand D, Saint-Amaux AL, Giovannini M. Tumor-suppression functions of Merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells. J Cell Sci. 2009;122(Pt 22):4141\u20139.","journal-title":"J Cell Sci"},{"issue":"3","key":"4281_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.devcel.2009.01.009","volume":"16","author":"MC Wilkes","year":"2009","unstructured":"Wilkes MC, Repellin CE, Hong M, Bracamonte M, Penheiter SG, Borg JP, et al. Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta. Dev Cell. 2009;16(3):433\u201344.","journal-title":"Dev Cell"},{"issue":"9","key":"4281_CR52","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/carcin\/bgy078","volume":"39","author":"MSV Mota","year":"2018","unstructured":"Mota MSV, Jackson WP, Bailey SK, Vayalil P, Landar A, Rostas JW 3, et al. Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer. Carcinogenesis. 2018;39(9):1165\u201375.","journal-title":"Carcinogenesis"},{"issue":"11","key":"4281_CR53","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1158\/1535-7163.MCT-17-1210","volume":"17","author":"JH Cho","year":"2018","unstructured":"Cho JH, Oh AY, Park S, Kang SM, Yoon MH, Woo TG, et al. Loss of NF2 induces TGF\u03b2 receptor 1-mediated noncanonical and oncogenic TGF\u03b2 signaling: implication of the therapeutic effect of TGF\u03b2 receptor 1 inhibitor on NF2 syndrome. Mol Cancer Ther. 2018;17(11):2271\u201384.","journal-title":"Mol Cancer Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04281-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:06:17Z","timestamp":1743962777000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04281-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4281"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04281-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.24.614711","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For patient sample collection: Title of the approved project: Vestibular Schwannoma. Name of the institutional approval committee: University of Miami IRB committee. Approval number: 20150637 Date of approval: 9\/26\/2017. We confirmed that the patient and their guardian provided written informed consent for participation in the study and\/or the use of samples.For hiPSCs usage: Title of the approved project: Molecular Basis of NonSyndromic Deafness. Name of the institutional approval committee: University of Miami IRB committee. Approval number: 20010415 Date of approval: 11\/5\/2007. The original source has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"163"}}